Unprecedented need and recommendations for harnessing data to guide future policy and practice for opioid use disorder treatment following COVID-19

[1]  Peter J. Rock,et al.  Signal of increased opioid overdose during COVID-19 from emergency medical services data , 2020, Drug and Alcohol Dependence.

[2]  Jennifer Thomas,et al.  Coronavirus Disease 2019 and Opioid Use-A Pandemic Within an Epidemic. , 2020, JAMA health forum.

[3]  Jeffrey P. Bratberg,et al.  Opioid Use Disorder and the Covid 19 Pandemic: A Call to Sustain Regulatory Easements and Further Expand Access to Treatment , 2020, Substance abuse.

[4]  A. Knopf.  DEA proposal for mobile methadone finally released , 2020 .

[5]  David K. Wyant,et al.  Compositional and contextual factors associated with drug overdose deaths in the United States , 2020, Journal of addictive diseases.

[6]  Holly Hedegaard,et al.  Drug Overdose Deaths in the United States, 1999-2018. , 2020, NCHS data brief.

[7]  D. Ciccarone.  The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis. , 2019, The International journal on drug policy.

[8]  J. Singer,et al.  Trajectories of injection drug use among people who use drugs in Vancouver, Canada, 1996-2017: Growth mixture modeling using data from prospective cohort studies. , 2019, Addiction.

[9]  R. Rosenheck,et al.  Comparison of opioid use disorder among male veterans and non‐veterans: Disorder rates, socio‐demographics, co‐morbidities, and quality of life , 2019, The American journal on addictions.

[10]  Na Wang,et al.  Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality , 2018, Annals of Internal Medicine.

[11]  W. Gellad,et al.  Medication-Assisted Treatment and Opioid Use Before and After Overdose in Pennsylvania Medicaid , 2017, JAMA.

[12]  K. Carroll,et al.  The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review. , 2017, The American journal of psychiatry.

[13]  J. Eibl,et al.  The effectiveness of telemedicine-delivered opioid agonist therapy in a supervised clinical setting. , 2017, Drug and alcohol dependence.

[14]  H. Connery.  Medication-Assisted Treatment of Opioid Use Disorder: Review of the Evidence and Future Directions , 2015, Harvard review of psychiatry.

[15]  S. Spear.  Reducing readmissions to detoxification: an interorganizational network perspective. , 2014, Drug and alcohol dependence.

[16]  Implementation of the Ryan Haight Online Pharmacy Consumer Protection Act of 2008. Interim final rule with request for comments. , 2009, Federal register.

[17]  N. Brown,et al.  Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. , 2004 .